Trial Outcomes & Findings for Role of Flavanols In Cardiovascular Function in Healthy Aging (NCT NCT01395277)

NCT ID: NCT01395277

Last Updated: 2015-08-10

Results Overview

Local heating of the cutaneous vasculature to 42 degree C is commonly used to evoke a maximal skin blood flow response (only at the site of local heating). This response is almost entirely dependent on nitric oxide mediated vasodilation.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

30 participants

Primary outcome timeframe

prior to (baseline) and 2 hours post beverage consumption

Results posted on

2015-08-10

Participant Flow

Participant milestones

Participant milestones
Measure
High Flavanol First Then Low Flavanol
The measurements will be made on all study participants on two separate visits to the laboratory; On the first visit measurements will be made before (baseline) and 2 hrs post consumption of a beverage with "high" flavanol content. On the second study visit measurements will be made before and 2 hrs following consumption of a beverage with "low" flavanol content. During the first visit the high flavanol measures will be performed before and 2 hours following consumption of a beverage containing 1,050 mg of Cocoa Flavanols mixed into 250 ml of distilled water. Measurements will be performed 2 hrs after consumption. During the second visit the low flavanol measures will be performed following consumption of a beverage containing 0 mg of Cocoa Flavanols mixed into 250 ml of distilled water. Measurements will be performed 2 hrs after consumption.
Low Flavanol First Then High Flavanol
The measurements will be made on all study participants on two separate visits to the laboratory; On the first visit measurements will be made before (baseline) and 2 hrs post consumption of a beverage with "low" flavanol content. On the second study visit measurements will be made before and 2 hrs following consumption of a beverage with "high" flavanol content. During the first visit the low flavanol measures will be performed before and 2 hours following consumption of a beverage containing 0 mg of Cocoa Flavanols mixed into 250 ml of distilled water. Measurements will be performed 2 hrs after consumption. During the second visit the high flavanol measures will be performed following consumption of a beverage containing 1,050 mg of Cocoa Flavanols mixed into 250 ml of distilled water. Measurements will be performed 2 hrs after consumption.
Overall Study
STARTED
15
15
Overall Study
COMPLETED
15
15
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Role of Flavanols In Cardiovascular Function in Healthy Aging

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
High Flavanol First Then Low Flavanol
n=15 Participants
The measurements will be made on all study participants on two separate visits to the laboratory; On the first visit measurements will be made before (baseline) and 2 hrs post consumption of a beverage with "high" flavanol content . On the second study visit measurements will be made before and 2 hrs following consumption of a beverage with "low" flavanol content. During the first visit the high flavanol measures will be performed following consumption of a beverage containing 1,050 mg of Cocoa Flavanols mixed into 250 ml of distilled water. Measurements will be performed 2 hrs after consumption. During the second visit the placebo trial (low flavanol group) will be performed following consumption of a beverage containing 0 mg of Cocoa Flavanols mixed into 250 ml of distilled water. Measurements will be performed 2 hrs after consumption.
Low Flavanol First Then High Flavanol
n=15 Participants
The measurements will be made on all study participants on two separate visits to the laboratory; On the first visit measurements will be made before (baseline) and 2 hrs post consumption of a beverage with "low" flavanol content. On the second study visit measurements will be made before and 2 hrs following consumption of a beverage with "high" flavanol content. During the first visit the low flavanol measures will be performed following consumption of a beverage containing 0 mg of Cocoa Flavanols mixed into 250 ml of distilled water. Measurements will be performed 2 hrs after consumption. During the second visit the high flavanol measures will be performed following consumption of a beverage containing 1,050 mg of Cocoa Flavanols mixed into 250 ml of distilled water. Measurements will be performed 2 hrs after consumption.
Total
n=30 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
8 Participants
n=5 Participants
7 Participants
n=7 Participants
15 Participants
n=5 Participants
Age, Categorical
>=65 years
7 Participants
n=5 Participants
8 Participants
n=7 Participants
15 Participants
n=5 Participants
Age, Continuous
68.4 years
STANDARD_DEVIATION 2.8 • n=5 Participants
67.5 years
STANDARD_DEVIATION 2.9 • n=7 Participants
68.0 years
STANDARD_DEVIATION 2.7 • n=5 Participants
Sex: Female, Male
Female
7 Participants
n=5 Participants
7 Participants
n=7 Participants
14 Participants
n=5 Participants
Sex: Female, Male
Male
8 Participants
n=5 Participants
8 Participants
n=7 Participants
16 Participants
n=5 Participants
Region of Enrollment
United States
15 participants
n=5 Participants
15 participants
n=7 Participants
30 participants
n=5 Participants
Mean Blood Pressure
85 mmHg
STANDARD_DEVIATION 8 • n=5 Participants
88 mmHg
STANDARD_DEVIATION 7 • n=7 Participants
87 mmHg
STANDARD_DEVIATION 6 • n=5 Participants

PRIMARY outcome

Timeframe: prior to (baseline) and 2 hours post beverage consumption

Local heating of the cutaneous vasculature to 42 degree C is commonly used to evoke a maximal skin blood flow response (only at the site of local heating). This response is almost entirely dependent on nitric oxide mediated vasodilation.

Outcome measures

Outcome measures
Measure
High Flavanol
n=30 Participants
The measurements will be made on all study participants on two separate occasions; 1) before and 2 hours following consumption of a beverage with "high" flavanol content (experimental trial), and 2) before and 2 hours following consumption of a beverage with "low" flavanol content (placebo trial). CocoaVia Dark Chocolate Flavored Drink: The experimental trial (high flavanol group) will be performed following consumption of a beverage containing 1,050 mg of Cocoa Flavanols. This cocoa flavanol powder will be purchased from Mars Incorporated (Hackettstown, New Jersey) and will be mixed into 250 ml of distilled water. The subjects will consume this beverage and measurements will be performed 2 hours after consumption.
Low Flavanol
n=30 Participants
The measurements will be made on all study participants on two separate occasions; 1) before and 2 hours following consumption of a beverage with "high" flavanol content (experimental trial), and 2) before and 2 hours following consumption of a beverage with "low" flavanol content (placebo trial). Placebo Trial: CocoaVia Dark Chocolate Flavored Drink: The placebo trial (low flavanol content) will be performed following consumption of a beverage containing 75 mg of Cocoa Flavanols. This cocoa flavanol powder will be purchased from Mars Incorporated (Hackettstown, New Jersey) and will be mixed into 250 ml of distilled water. The subjects will consume this beverage and measurements will be performed 2 hours after consumption.
Cutaneous Blood Flow Response to Local Heating of the Skin.
68 percent change in mean skin blood flow
Standard Deviation 10.6
70 percent change in mean skin blood flow
Standard Deviation 12.3

SECONDARY outcome

Timeframe: Prior to (baseline) and 2 hours following beverage consumption

Assessment of pulse wave velocity in the common carotid artery and the femoral artery provides an index of arterial stiffness.

Outcome measures

Outcome measures
Measure
High Flavanol
n=30 Participants
The measurements will be made on all study participants on two separate occasions; 1) before and 2 hours following consumption of a beverage with "high" flavanol content (experimental trial), and 2) before and 2 hours following consumption of a beverage with "low" flavanol content (placebo trial). CocoaVia Dark Chocolate Flavored Drink: The experimental trial (high flavanol group) will be performed following consumption of a beverage containing 1,050 mg of Cocoa Flavanols. This cocoa flavanol powder will be purchased from Mars Incorporated (Hackettstown, New Jersey) and will be mixed into 250 ml of distilled water. The subjects will consume this beverage and measurements will be performed 2 hours after consumption.
Low Flavanol
n=30 Participants
The measurements will be made on all study participants on two separate occasions; 1) before and 2 hours following consumption of a beverage with "high" flavanol content (experimental trial), and 2) before and 2 hours following consumption of a beverage with "low" flavanol content (placebo trial). Placebo Trial: CocoaVia Dark Chocolate Flavored Drink: The placebo trial (low flavanol content) will be performed following consumption of a beverage containing 75 mg of Cocoa Flavanols. This cocoa flavanol powder will be purchased from Mars Incorporated (Hackettstown, New Jersey) and will be mixed into 250 ml of distilled water. The subjects will consume this beverage and measurements will be performed 2 hours after consumption.
Pulse Wave Velocity / Arterial Stiffness
2.5 cm / sec
Standard Deviation 0.2
2.7 cm / sec
Standard Deviation .30

Adverse Events

High Flavanol First Then Low Flavanol

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Low Flavanol First Then High Flavanol

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. R. Matthew Brothers

University of Texas at Austin

Phone: 512-232-6016

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place